Results 141 to 150 of about 19,227 (236)

Provider variability in the intraoperative use of neuromuscular blocking agents: a retrospective multicentre cohort study. [PDF]

BMJ Open, 2021
Althoff FC, Xu X, Wachtendorf LJ, Shay D, Patrocinio M, Schaefer MS, Houle TT, Fassbender P, Eikermann M, Wongtangman K.   +9 more
europepmc   +1 more source

Anterior Mediastinal Mature Teratoma Presenting With Mediastinal Mass Syndrome in a Six‐Month‐Old Infant: Diagnostic Pitfalls and Anesthetic Challenges

Clinical Case Reports, Volume 14, Issue 10, October 2026.
ABSTRACT An anterior mediastinal mass in infants can present with life‐threatening complications due to airway and vascular compression. We report a six‐month‐old infant with a mature teratoma presenting as mediastinal mass syndrome, highlighting the diagnostic challenges and anesthetic risks involved.
Ghamar Taj Khanbabaee, Ali Shafiee, Zahra Ghomi, Nastaran Sadat Mahdavi, Leili Mohajerzadeh, Yalda Nilipour, Seyed Alireza Mahdavi   +6 more
wiley   +1 more source

Pharmacological strategies to minimize or avoid neuromuscular blocking agents during general anesthesia: a comprehensive approach from airway management to surgical requirements. [PDF]

Front Pharmacol
Zhan FQ, Guo R.
europepmc   +1 more source

Reducing the dose of neuromuscular blocking agents with adjuncts: a systematic review and meta-analysis. [PDF]

Br J Anaesth, 2021
Weber V, Abbott TEF, Ackland GL.
europepmc   +1 more source

Anesthetic Management and Perioperative Outcome of Emergency Laparotomy in a Patient With Advanced Motor Neurone Disease: A Case Report

Clinical Case Reports, Volume 14, Issue 10, October 2026.
Schematic summary of the perioperative management and clinical course of emergency laparotomy in a patient with advanced motor neurone disease (MND). ABSTRACT Motor neurone disease (MND) presents significant perioperative challenges due to progressive respiratory muscle weakness, bulbar dysfunction, autonomic instability, and altered sensitivity to ...
Sherif Elmahgoub, Abdou Elshawa, Sean Flannery   +2 more
wiley   +1 more source

In silico assessment of neuromuscular blocking agents and fluoroquinolones as ligands of the Mas-related G protein-coupled receptor X2. [PDF]

Pharmacol Rep
Rybka H, Dziadowiec A, Kwitniewski M, Bulanda D, Kitel R, Porębski G.   +5 more
europepmc   +1 more source

Bioassays in Allergy: Technical Characteristics, Limitations, and Pathways to Clinical Implementation—An EAACI Position Paper

Clinical and Translational Allergy, Volume 16, Issue 10, October 2026.
ABSTRACT Bioassays offer functional readouts of immune responses through specific biomarkers, providing mechanistic insight beyond conventional serology. By capturing cellular activation, tissue‐level changes, and molecular signaling, they hold promise for refining allergy diagnosis, risk stratification, and treatment monitoring, contributing to ...
Cagatay Karaaslan, Oscar Palomares, Busra Kilic, Cristobalina Mayorga, Hans Jürgen Hoffmann, Bernadette Eberlein, Edward Knol, Ruben Fernandez‐Santamaria, Joana Vitte, Elena Izquierdo, Cristina Gomez‐Casado, Marina Perez‐Gordo, Araceli Diaz Perales, Maria M. Escribese   +13 more
wiley   +1 more source

Aging of Skeletal Muscle: From Molecular Mechanisms to Therapeutic Interventions

MedComm, Volume 7, Issue 10, October 2026.
Skeletal muscle aging is driven by coordinated local breakdown across myofibers, stem and stromal cells, immune and vascular compartments, and neuromuscular control. These mechanisms promote mitochondrial dysfunction, inflammation, senescence, impaired regeneration, fibrosis, myosteatosis, denervation, and functional decline.
Ting Liu, Yaomin Hu
wiley   +1 more source

Neuromuscular Blocking Agents and Reversal Agents Usage, and Neuromuscular Blockade Monitoring in the Intensive Care Unit - Review Article. [PDF]

Int J Gen Med
Szewczyk M, Bieniecka A, Sobolewski K, Banasiak Ł, Grabarczyk Ł.   +4 more
europepmc   +1 more source

Neuromuscular Blocking Agents and Reversal Agents Among Hospitalized Children: A Cerner Database Study. [PDF]

Hosp Pharm, 2021
Zhong W, Liu X, Bash LD, Bortnichak E, Horrow J, Koro C.   +5 more
europepmc   +1 more source